نتایج جستجو برای: سلولهای t مهندسی شده car t cell

تعداد نتایج: 2678626  

Journal: :Cancer immunology research 2015
Carolina Berger Daniel Sommermeyer Michael Hudecek Michael Berger Ashwini Balakrishnan Paulina J Paszkiewicz Paula L Kosasih Christoph Rader Stanley R Riddell

Genetic engineering of T cells for adoptive transfer by introducing a tumor-targeting chimeric antigen receptor (CAR) is a new approach to cancer immunotherapy. A challenge for the field is to define cell surface molecules that are both preferentially expressed on tumor cells and can be safely targeted with T cells. The orphan tyrosine kinase receptor ROR1 is a candidate target for T-cell thera...

Journal: :The Journal of clinical investigation 2011
Barbara Savoldo Carlos Almeida Ramos Enli Liu Martha P Mims Michael J Keating George Carrum Rammurti T Kamble Catherine M Bollard Adrian P Gee Zhuyong Mei Hao Liu Bambi Grilley Cliona M Rooney Helen E Heslop Malcolm K Brenner Gianpietro Dotti

Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulator...

Journal: :Cancer immunology research 2017
Giedre Krenciute Brooke L Prinzing Zhongzhen Yi Meng-Fen Wu Hao Liu Gianpietro Dotti Irina V Balyasnikova Stephen Gottschalk

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and is virtually incurable with conventional therapies. Immunotherapy with T cells expressing GBM-specific chimeric antigen receptors (CAR) is an attractive approach to improve outcomes. Although CAR T cells targeting GBM antigens, such as IL13 receptor subunit α2 (IL13Rα2), HER2, and EGFR variant III (EGFRvIII), have had a...

سعیده کاوسی محمدرضا نوری‌‌دلویی نازنین رحیمی راد

درمان‌های برپایة گیرنده‌های آنتی‌ژن کایمری(CAR) سلول‌های T، به‌عنوان یکی از روش‌های نوین ایمنی درمانی، تحول شگرفی را در درمان سرطان پدید آورده‌اند. ازآنجا که CAR از یک آنتی بادی ایجاد می‌شوند، سلول حاصل دارای ویژگی هدف‌گیری مطلوب یک آنتی‌بادی مانند نیازنداشتن به شناسایی توسط مجموعة سازگاری بافتی (MHC) و توانایی شناسایی آنتی‌ژن‌های خودی است. این مزایای بالقوه، به شناسایی آنتی‌ژن‌های ویژة سلول‌ها...

Journal: :Cancers 2016
Vita Golubovskaya Lijun Wu

This review is focused on different subsets of T cells: CD4 and CD8, memory and effector functions, and their role in CAR-T therapy--a cellular adoptive immunotherapy with T cells expressing chimeric antigen receptor. The CAR-T cells recognize tumor antigens and induce cytotoxic activities against tumor cells. Recently, differences in T cell functions and the role of memory and effector T cells...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید